Having trouble viewing this email? Click here .

May 2024    


New Global Grants Announced in Africa and the Middle East

According to the World Health Organization, maternal mortality rates have improved over the past several decades, however communities across Africa and the Middle East continue to face an array of factors limiting access to equitable maternal health care. To help address these challenges, we have made a new round of Merck for Mothers Global Grants, extending reach and impact in Algeria, Liberia, South Africa and Türkiye.

Join Merck for Mothers at World Health Assembly 2024

This event will explore how more collaborative engagement with local private sector entities can advance equitable access to quality maternal health care and response to public health goals in low- and middle-income countries. Hear from leading voices including Dr. Nakhumicha S. Wafula, Cabinet Secretary for Health, Kenya and the Health and Social Welfare, Federal Ministry of Health and Social Welfare, Nigeria, Prof. Muhammad Ali Pate.

Merck Releases New Report on "Improving Maternal Health Across Europe"

We have released a new report examining the state of maternal mortality across Europe and solutions supported by Merck for Mothers. While a significant decline in maternal mortality occurred in Europe, the World Health Organization estimates that 1,000 European women still die annually due to complications of pregnancy or childbirth. Merck for Mothers works to address challenges across the maternal health space by improving access to quality health care and family planning services with programs tailored to meet the needs of women everywhere, especially those from underserved and marginalized communities.

If you no longer wish to receive updates from Merck for Mothers please click here to opt out.

At Merck, our global privacy program is based on building and preserving the trust of our stakeholders in how we protect personal information about them. Please read more about our privacy commitment . For more information, please read our Global Data Practices Notice for Healthcare Professionals .

If you have questions relating to Merck prescription products, your medical condition or personal health matters, please contact your physician or healthcare provider since he or she is most familiar with your medical condition. Merck cannot respond to questions about general medical information or information regarding your specific condition. To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080 .

To ensure delivery of this e-newsletter, add newsletter@merckformothers.com to your address book.

This email was sent by: Merck for Mothers, Merck & Co., Inc., Rahway, NJ, USA